1. [Cytotoxicity of chimera peptides incorporating sequences of cyclin kinases inhibitors].
- Author
-
Kharchenko VP, Kulinich VG, Lunin VG, Filiasova EI, Shishkin AM, Sergeenko OV, Riazanova EM, Voronina OL, and Bozhenko VK
- Subjects
- Amino Acid Sequence, Cell Line, Tumor, Cyclin-Dependent Kinase Inhibitor p16 biosynthesis, Cyclin-Dependent Kinase Inhibitor p16 genetics, Cyclin-Dependent Kinase Inhibitor p21 biosynthesis, Cyclin-Dependent Kinase Inhibitor p21 genetics, Gene Expression Regulation, Neoplastic, Genes, p16, Genes, p53, Humans, Jurkat Cells, Molecular Sequence Data, Peptides pharmacology, Antennapedia Homeodomain Protein metabolism, Apoptosis drug effects, Chimera, Cyclin-Dependent Kinase Inhibitor p16 pharmacology, Cyclin-Dependent Kinase Inhibitor p21 pharmacology, Gene Products, tat metabolism
- Abstract
The study is concerned with proapoptotic properties of chimera peptides which incorporate sequences of inhibitors of cyclin kinases p161NK4a and p21CIP/WAF1 as well as internalized sequences (Antp and tat). Sequences of the p16 type appeared to be more cytotoxic than the p21 one. Cytotoxic effect proved dependent on orientation with respect to the C or N terminal point of a polypeptide chain rather than on chimera sequence extent. Although p16 endogenous synthesis did not influence chimera peptide levels, apoptosis did not take place in certain cellular lines. Due to the rather unsophisticated nature of such synthesis, it might be used in designing individually-tailored chemotherapeutic drugs.
- Published
- 2007